456 related articles for article (PubMed ID: 16643891)
1. Antibody-directed targeting of angiostatin's receptor annexin II inhibits Lewis Lung Carcinoma tumor growth via blocking of plasminogen activation: possible biochemical mechanism of angiostatin's action.
Sharma MR; Rothman V; Tuszynski GP; Sharma MC
Exp Mol Pathol; 2006 Oct; 81(2):136-45. PubMed ID: 16643891
[TBL] [Abstract][Full Text] [Related]
2. Angiogenesis-associated protein annexin II in breast cancer: selective expression in invasive breast cancer and contribution to tumor invasion and progression.
Sharma MR; Koltowski L; Ownbey RT; Tuszynski GP; Sharma MC
Exp Mol Pathol; 2006 Oct; 81(2):146-56. PubMed ID: 16643892
[TBL] [Abstract][Full Text] [Related]
3. Angiostatin binds to tyrosine kinase substrate annexin II through the lysine-binding domain in endothelial cells.
Tuszynski GP; Sharma MR; Rothman VL; Sharma MC
Microvasc Res; 2002 Nov; 64(3):448-62. PubMed ID: 12453439
[TBL] [Abstract][Full Text] [Related]
4. Specific interaction of angiostatin with integrin alpha(v)beta(3) in endothelial cells.
Tarui T; Miles LA; Takada Y
J Biol Chem; 2001 Oct; 276(43):39562-8. PubMed ID: 11514539
[TBL] [Abstract][Full Text] [Related]
5. The role of annexin II in angiogenesis and tumor progression: a potential therapeutic target.
Sharma MC; Sharma M
Curr Pharm Des; 2007; 13(35):3568-75. PubMed ID: 18220793
[TBL] [Abstract][Full Text] [Related]
6. Angiostatin's molecular mechanism: aspects of specificity and regulation elucidated.
Wahl ML; Kenan DJ; Gonzalez-Gronow M; Pizzo SV
J Cell Biochem; 2005 Oct; 96(2):242-61. PubMed ID: 16094651
[TBL] [Abstract][Full Text] [Related]
7. Breast cancer cell surface annexin II induces cell migration and neoangiogenesis via tPA dependent plasmin generation.
Sharma M; Ownbey RT; Sharma MC
Exp Mol Pathol; 2010 Apr; 88(2):278-86. PubMed ID: 20079732
[TBL] [Abstract][Full Text] [Related]
8. Antibody-directed neutralization of annexin II (ANX II) inhibits neoangiogenesis and human breast tumor growth in a xenograft model.
Sharma M; Blackman MR; Sharma MC
Exp Mol Pathol; 2012 Feb; 92(1):175-84. PubMed ID: 22044461
[TBL] [Abstract][Full Text] [Related]
9. Radiation therapy to a primary tumor accelerates metastatic growth in mice.
Camphausen K; Moses MA; Beecken WD; Khan MK; Folkman J; O'Reilly MS
Cancer Res; 2001 Mar; 61(5):2207-11. PubMed ID: 11280788
[TBL] [Abstract][Full Text] [Related]
10. The p11 subunit of the annexin II tetramer plays a key role in the stimulation of t-PA-dependent plasminogen activation.
Kassam G; Le BH; Choi KS; Kang HM; Fitzpatrick SL; Louie P; Waisman DM
Biochemistry; 1998 Dec; 37(48):16958-66. PubMed ID: 9836589
[TBL] [Abstract][Full Text] [Related]
11. A recombinant human angiostatin protein inhibits experimental primary and metastatic cancer.
Sim BK; O'Reilly MS; Liang H; Fortier AH; He W; Madsen JW; Lapcevich R; Nacy CA
Cancer Res; 1997 Apr; 57(7):1329-34. PubMed ID: 9102221
[TBL] [Abstract][Full Text] [Related]
12. Angiostatin and plasminogen share binding to endothelial cell surface actin.
Dudani AK; Ben-Tchavtchavadze M; Porter S; Tackaberry E
Biochem Cell Biol; 2005 Feb; 83(1):28-35. PubMed ID: 15746964
[TBL] [Abstract][Full Text] [Related]
13. Plasminogen derivatives encoding kringles 1-4 and kringles 1-5 exert indirect antiangiogenic and direct antitumoral effects in experimental lung cancer.
Schmitz V; Raskopf E; Gonzalez-Carmona MA; Vogt A; Kornek M; Sauerbruch T; Caselmann WH
Cancer Invest; 2008 Jun; 26(5):464-70. PubMed ID: 18568768
[TBL] [Abstract][Full Text] [Related]
14. The tumor-suppressing activity of angiostatin protein resides within kringles 1 to 3.
MacDonald NJ; Murad AC; Fogler WE; Lu Y; Sim BK
Biochem Biophys Res Commun; 1999 Oct; 264(2):469-77. PubMed ID: 10529387
[TBL] [Abstract][Full Text] [Related]
15. Functional hierarchy of plasminogen kringles 1 and 4 in fibrinolysis and plasmin-induced cell detachment and apoptosis.
Ho-Tin-Noé B; Rojas G; Vranckx R; Lijnen HR; Anglés-Cano E
FEBS J; 2005 Jul; 272(13):3387-400. PubMed ID: 15978044
[TBL] [Abstract][Full Text] [Related]
16. Thrombin induces endothelial cell-surface exposure of the plasminogen receptor annexin 2.
Peterson EA; Sutherland MR; Nesheim ME; Pryzdial EL
J Cell Sci; 2003 Jun; 116(Pt 12):2399-408. PubMed ID: 12724354
[TBL] [Abstract][Full Text] [Related]
17. Angiostatin potentiates cyclophosphamide treatment of metastatic disease.
Mauceri HJ; Seetharam S; Beckett MA; Schumm LP; Koons A; Gupta VK; Park JO; Manan A; Lee JY; Montag AG; Kufe DW; Weichselbaum RR
Cancer Chemother Pharmacol; 2002 Nov; 50(5):412-8. PubMed ID: 12439600
[TBL] [Abstract][Full Text] [Related]
18. Differential binding of plasminogen, plasmin, and angiostatin4.5 to cell surface beta-actin: implications for cancer-mediated angiogenesis.
Wang H; Doll JA; Jiang K; Cundiff DL; Czarnecki JS; Wilson M; Ridge KM; Soff GA
Cancer Res; 2006 Jul; 66(14):7211-5. PubMed ID: 16849568
[TBL] [Abstract][Full Text] [Related]
19. Characterization and biological activities of recombinant human plasminogen kringle 1-3 produced in Escherichia coli.
You WK; So SH; Sohn YD; Lee H; Park DH; Chung SI; Chung KH
Protein Expr Purif; 2004 Jul; 36(1):1-10. PubMed ID: 15177278
[TBL] [Abstract][Full Text] [Related]
20. Mutation of human plasminogen kringle 1-5 enhances anti-angiogenic action via increased interaction with integrin alpha(v)beta(3).
Chang PC; Chang YJ; Wu HL; Chang CW; Lin CI; Wang WC; Shi GY
Thromb Haemost; 2008 Apr; 99(4):729-38. PubMed ID: 18392331
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
